SAMANTHA WILLIAMS: Open Payments
NPI 1588158877 · BIRMINGHAM, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$964 in 56 payments from 15 companies in 2025. Trend: 2023 $1,524 · 2024 $1,212 · 2025 $964
Food & beverage: $964
| Company | Payments | Amount |
|---|---|---|
| Dexcom, Inc. | 13 | $157 |
| GlaxoSmithKline, LLC. | 7 | $143 |
| Astellas Pharma US Inc | 5 | $109 |
| PFIZER INC. | 6 | $104 |
| Teleflex LLC | 4 | $85 |
| Lilly USA, LLC | 5 | $77 |
| Novo Nordisk Inc | 4 | $69 |
| Abbott Laboratories | 2 | $45 |
| Exact Sciences Corporation | 2 | $36 |
| AstraZeneca Pharmaceuticals LP | 2 | $34 |
Products named: Dexcom G6 Transmitter, TRELEGY ELLIPTA, Veozah, ARROW, Ozempic, PREVNAR 20, FREESTYLE LIBRE 3, MOUNJARO.
Industry payments across AL — which companies pay providers there.
